Indicative prices, multi-year financials, shareholding and corporate events for unlisted and pre-IPO companies — with the source and date on every figure. Research first, then raise an enquiry with our desk.
Consumer · Pre-IPO
₹6.3
—| Date | Indicative price (₹) |
|---|---|
| 2026-03-09 | 5.53 |
| 2026-04-09 | 5.9 |
| 2026-05-09 | 5.53 |
| 2026-06-09 | 5.85 |
| 2026-07-09 | 6.23 |
| 2026-08-09 | 5.85 |
| 2026-09-09 | 6.3 |
7 dated snapshots · updated 2 Oct 2026
Indicative prices with the date and source behind every figure.
| # | Company | Mkt cap | P/E | Price | 1M | 1Y | Trend | Actions |
|---|---|---|---|---|---|---|---|---|
| 1 | AB InBev IndiaConsumer | ₹56,410 Cr | — | ₹555 | — | — | — | Enquire |
| 2 | PharmeasyConsumer | ₹10,730 Cr | — | ₹6.30 | — | — | Enquire | |
| 3 | Capgemini IndiaTechnology | ₹62,835 Cr | 15.3x | ₹10,650 | — | — | — | Enquire |
| 4 | CSKConsumer | ₹9,410 Cr | 82.7x | ₹248 | — | — | Enquire | |
| 5 | CIALIndustrials | ₹21,520 Cr | 40.9x | ₹450 | — | — | Enquire | |
| 6 | ESDS SoftwareTechnology | — | — | — | — | — | — | Enquire |
| 7 | Garuda AerospaceIndustrials | ₹2,284 Cr | 88.1x | ₹438 | — | — | Enquire | |
| 8 | GFCL EV Product LTDIndustrials | ₹31,765 Cr | — | ₹43.00 | — | — | Enquire |
The names our desk is asked about most often this month.
No order book, no instant execution — availability and price are confirmed before anything settles.
Read the financials, shareholding, valuation ratios and risks. Every figure carries its source and the date it was reported.
Tell us the company and quantity. You get an enquiry ID immediately and can follow every stage from your account.
Our desk confirms availability and a firm price. Shares transfer to your demat account after KYC and payment.
Every company sits in one sector and one industry, so a filter lands on the same set every time.
What we publish is marked as fact or as opinion, and every note names its sources.
Capex cycle · Margin trend
The Sanand line crossed break-even utilisation in FY2026 and the company reported its first positive PAT. We look at what has to stay true for that to repeat.
IPO pipeline · Regulation
Eleven of the companies we track have filed a draft prospectus in the last eighteen months. We set out where each one stands, what is still outstanding, and why a filing is not a timetable.
Valuation · Regulation
Exchange revenue scales with turnover at almost no incremental cost. We walk through what that means for the margin profile and where the fee-cap risk actually sits.
Unlisted shares work differently from listed ones — the price, the settlement and the exit all behave differently. Start here.
Read all FAQsRaise an enquiry and our desk confirms availability and a firm price before anything is settled. You get an enquiry ID immediately and can follow every stage from your account. There is no order book and no obligation.
